Baki Agbas

Baki Agbas is Professor of Biosciences at Kansas City University, leading research on biomarker development for neurodegenerative diseases including Alzheimer's and ALS. His laboratory investigates mitochondrial dysfunction, brain-derived exosomes, and proteolytic systems to identify blood-based diagnostic tools.

Research focuses on four key areas:

• Blood-based biomarkers using platelets/exosomes
• Mitochondrial respiration profiles
• Neural exosome characterization
• Dysfunctional proteolytic pathways

Recent publications (2020-2024) demonstrate consistent focus on TDP-43 protein dynamics across ALS and Alzheimer's models, with methodological innovations in exosome isolation and platelet biomarker validation. Collaborative clinical trials include Rasagilin-80 and oxaloacetate therapies.

The laboratory maintains active collaborations with University of Kansas Medical Center on NIH-funded biomarker validation projects and clinical trial support.